Burcon Engages Financial Advisor

Vancouver, Canada, November 6 (ots/PRNewswire) - Burcon NutraScience
Corporation (TSX-V: BU) announces today the appointment of BMO
Capital Markets to act as exclusive financial advisor to Burcon in
connection with a process to identify and pursue strategic
alternatives for the commercialization of its innovative food
technology.

In engaging BMO Capital Markets, Burcon is initiating an
extensive review of alternative strategies for maximizing shareholder
value arising from Burcon's intellectual property portfolio including
the recently announced soy protein isolate technology and
CLARISOY(TM).

Mr. Johann F. Tergesen, Burcon's President and C.O.O. noted "The
goal of this engagement is simple: maximizing the value of Burcon and
Burcon's intellectual property portfolio. We have been working with
BMO Capital Markets and their food and agribusiness teams in Toronto
and Chicago, who understand the potential of our company and have
formidable credentials in the agribusiness and food industries. We
have many opportunities in front of us and we are excited to have BMO
Capital Markets helping us to chart a course of action."

About Burcon NutraScience

Burcon is a research and development company developing a
portfolio of composition, application, and process patents around its
plant protein extraction and purification technology. The goal of
Burcon's research is to develop its patented process to utilize
inexpensive oilseed meals for the production of purified plant
proteins that exhibit valuable nutritional, functional or
nutraceutical profiles. Burcon, in conjunction with Archer Daniels
Midland, is currently focusing its efforts on developing the world's
first commercial canola proteins, Puratein(R) and Supertein(TM).
Canola, recognized for its nutritional qualities, is the
second-largest oilseed crop in the world after soybeans. Burcon's
goal is to develop Puratein(R) and Supertein(TM) to participate with
soy, dairy, and egg proteins in the expanding multi-billion-dollar
protein ingredient market, with potential uses in prepared foods,
nutritional supplements, and personal care products.

ON BEHALF OF THE BOARD OF DIRECTORS
"Johann F. Tergesen"
Johann F. Tergesen
President & Chief Operating Officer

The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information
contained herein. This press release contains forward-looking
statements that involve risks and uncertainties. These
forward-looking statements relate to, among other things, plans and
timing for the introduction or enhancement of our products,
statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in
this press release that are not historical fact. Our expectations
regarding the prospect for future success depend upon our ability to
develop and sell products, which we do not produce today and cannot
be sold without further research and development. When used in this
press release, the words "goal," "intend," "believes" and "potential"
and similar expressions, generally identify forward-looking
statements. These statements reflect our current expectations. They
are subject to a number of risks and uncertainties. In light of the
many risks and uncertainties surrounding the development of a source
of protein from canola meal, you should understand that we cannot
assure you that the forward looking statements contained in this
press release will be realized.

For further information: Jade Cheng, Chief Financial Officer,
Burcon NutraScience Corporation, +1-604-733-0896, 888-408-7960
toll-free, jcheng@burcon.ca, http://www.burcon.ca; AXINO AG, Sven
Olsson, Investor Relations Europe, Konigstrasse 26 70173 Stuttgart,
Germany, Tel. +49-711-25-35-92-30, Fax +49-711-25-35-92-33,
olsson@axino.de, http://www.burcon.net/

ots Originaltext: Burcon NutraScience Corporation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, +1-604-733-0896, 888-408-7960 toll-free,
jcheng@burcon.ca; AXINO AG, Sven Olsson, Investor Relations Europe,
Konigstrasse 26 70173 Stuttgart, Germany, Tel. +49-711-25-35-92-30,
Fax +49-711-25-35-92-33, olsson@axino.de